Pool Corporation CFO to Attend the UBS Industrials and Transportation Conference
Nov 10, 2016 21:40 pm UTC| Business
COVINGTON, La., Nov. 10, 2016 -- Pool Corporation (NASDAQ:POOL)announced today that Mark W. Joslin, Senior Vice President and CFO, will be participating in the 2016 UBS Industrials and Transportation Conference on...
K2M Group Holdings, Inc. Announces Proposed Sale of Shares of Common Stock by Selling Stockholders
Nov 10, 2016 21:39 pm UTC| Business
LEESBURG, Va., Nov. 10, 2016 -- K2M Group Holdings, Inc. (Nasdaq:KTWO) ("K2M" or the "Company"), a global medical device company focused on designing, developing and commercializing innovative and proprietary complex...
The Children’s Place to Webcast Review of Third Quarter 2016 Financial Results
Nov 10, 2016 21:33 pm UTC| Business
SECAUCUS, N.J., Nov. 10, 2016 -- The Children’s Place, Inc. (Nasdaq:PLCE) today announced that in conjunction with the release of its Third Quarter 2016 financial results, you are invited to listen to the Company’s...
3D Systems Extends Patient-Specific 3D Modeling and Printing Service to Aid Cardiology Procedures
Nov 10, 2016 21:30 pm UTC| Business
-New pliable MultiJet Printing material mimics patient physiology, enabling realistic practice of cuts, sutures and grafts ...
Kinsale Capital Group, Inc. Reports 2016 Third Quarter Results
Nov 10, 2016 21:30 pm UTC| Business
RICHMOND, Va., Nov. 10, 2016 -- Kinsale Capital Group, Inc. (NASDAQ:KNSL) reported net income of $8.0 million for the third quarter of 2016 compared to $5.9 million for the third quarter of 2015. Net income was $19.3...
Dyadic International Reports Third Quarter 2016 Financial Results
Nov 10, 2016 21:30 pm UTC| Business
JUPITER, Fla., Nov. 10, 2016 -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and leveraging the patented and proprietary C1 expression system to help...
ADMA Biologics Reports Third Quarter 2016 Results
Nov 10, 2016 21:30 pm UTC| Business
RAMSEY, N.J., Nov. 10, 2016 -- ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics for the proposed...